Weave reports Q3 EPS 3c, consensus 2c

Reports Q3 revenue $61.3M, consensus $60.67M. “We delivered another strong quarter, marked by accelerating revenue growth, non-GAAP profitability, and free cash flow as well as significant advancements across our product roadmap,” said Brett White, CEO of Weave (WEAV). “The SMB healthcare market is evolving rapidly, with technology playing a greater role in how practices attract, engage, and retain patients. Weave is uniquely positioned to lead in this next phase of transformation. Our scale, brand, and deep expertise in SMB healthcare give us an advantage.”